Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P17
Within normal range
vs 2Y Ago
-3.8x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-42.50%
2024-9.84%
202311.27%
2022-235.49%
2021-23.17%
20200.00%
20190.00%